…Neoadjuvant immunotherapy has increased rates of pathological complete response (pCR) in …
Neoadjuvant chemoimmunotherapy
This treatment is selected. Its supporting articles are shown below.
Articles mentioning Neoadjuvant chemoimmunotherapy
7 articles · page 1 of 1…s of pathological response and event-free survival, positioning chemo-IO as the new global standard for stage IB–IIIA NSCLC. Yet these a…
…tes and survival outcomes with the addition of pembrolizumab to neoadjuvant chemotherapy. However, long-term immune-related adverse events (irAEs) remai…
…mples predicted poorer outcomes in patients with CCA undergoing neoadjuvant chemoimmunotherapy and was associated with cholesterol accumulation within tumours…
… the multidisciplinary team’s conclusion, the patient underwent neoadjuvant chemoimmunotherapy (nivolumab, carboplatin and paclitaxel) followed by surgery (ri…
… adenocarcinoma (LUAD) patients exhibit intrinsic resistance to neoadjuvant chemoimmunotherapy (N=816 trial cohort), underscoring an unmet need for mechanism-…
…ions from a patient with MPLC who exhibited varied responses to neoadjuvant chemoimmunotherapy. Further verification was conducted through external single-cel…